![](/img/cover-not-exists.png)
“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR
Sartini, Alessandro, Di Girolamo, Maria, Bertani, Angela, Villa, EricaVolume:
21
Language:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1097/mib.0000000000000604
Date:
November, 2015
File:
PDF, 64 KB
english, 2015